
LIN · Nasdaq
Expected to report Feb 4, 2027 — estimated from last year’s reporting date.
Consensus is $4.50 EPS for Dec 2026 across 5 estimates, ranging $4.45 to $4.59.
Linde delivered $4.59 of adjusted EPS, 1.55% above the $4.52 consensus and 9% above the year-ago quarter. Revenue reached $9.404 billion, up 9% year over year and about 1% from Q2; underlying growth was 5%, split between pricing and volume. The contrast between adjusted and reported results defined the print: reported diluted EPS fell 11% to $3.66 and operating income declined to $2.150 billion from $2.37 billion a year ago, while adjusted operating profit rose 8% to $2.763 billion. Linde attributed the reported-versus-adjusted difference to purchase accounting impacts and cost-reduction-program and other charges.
Demand and pricing supported growth across the regions, with Americas and APAC leading underlying sales gains and electronics among the principal drivers. Cash generation remained strong, with $3.169 billion of operating cash flow and $1.777 billion of free cash flow after capital expenditure. Linde reaffirmed a full-year adjusted EPS range of $17.82–$17.92, representing 8%–9% growth under its assumed 2% currency benefit, and expects Q4 adjusted EPS of $4.40–$4.50. It also reported an $11 billion project backlog and robust proposal activity, particularly in electronics.
Adjusted diluted EPS of $4.59 was up 9% year over year and modestly ahead of the $4.52 consensus. Adjusted net income rose 7% to $2.122 billion, and adjusted operating profit grew 8% to $2.763 billion. The adjusted operating margin was 29.4%. By contrast, reported operating profit was $2.150 billion and reported net income was $1.692 billion; reported diluted EPS of $3.66 was down 11% from $4.09 in Q3 FY2025. Linde said adjusted figures exclude purchase accounting impacts from Linde AG and cost-reduction-program and other charges. Reported operating margin was 22.9%, 30 basis points below the prior year, but flat excluding cost pass-through effects.
Sales of $9.404 billion were up 9% year over year, including 1% favorable currency. Underlying sales growth of 5% reflected 3% price attainment and 2% higher volume. Linde cited electronics, chemicals and energy, and manufacturing among the principal end markets supporting volume growth. Sequentially, revenue increased from $9.29 billion in Q2.
Operating cash flow increased 8% year over year to $3.169 billion. After $1.392 billion of capital expenditures, free cash flow was $1.777 billion. Linde returned $1.685 billion to shareholders through dividends and share repurchases, net of issuances. Full-year 2026 capital expenditures are expected to be $5.5–$6.0 billion to fund growth and maintenance, including the sale-of-gas project backlog.
Linde expects Q4 adjusted diluted EPS of $4.40–$4.50, up 5%–7% year over year, with no expected foreign-currency translation impact. Full-year adjusted EPS guidance is $17.82–$17.92, up 8%–9% assuming a 2% favorable currency contribution. The project backlog stands at $11 billion, including $7.9 billion of contractual sale-of-gas projects. Management cited robust customer proposal activity, particularly in electronics, and expects continued backlog growth.